Eukarys
Évry
About Eukarys
C3P3 is the world’s first non-viral, artificial eukaryotic expression system that autonomously synthesizes the messenger RNA (s) of interest (mRNA) in the cytoplasm of the host cell in a high-throughput and efficient manner, allowing high expression of the target proteins. Until late 2000s, the development of an artificial eukaryotic expression system was nearly impossible due to the amazing complexity of eukaryotic post-transcriptional mRNA modifications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Aug 2025)
- Website: eukarys.comenc3p3-the-first-ever-non-viral-eukaryotic-artificial-expression-system
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/eukarys-2226106 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.